NeuroPace Announces RNS System Enhancements Designed to Streamline Care

Neuropace Pdms. BrainResponsive Neurostimulation RNS System All — NeuroPace, Inc. NeuroPace technical experts; Interactive Activity Trend Chart NeuroPace may review the information and any photographs you provide for potential publication on our website

Neurostimulation devices to treat epilepsy — NeuroPace, Inc.
Neurostimulation devices to treat epilepsy — NeuroPace, Inc. from www.neuropace.com

Customer Support: 1-866-726-3876 (Toll Free in the United States) Website: www.NeuroPace.com If NeuroPace decides to use your story, we will contact you and ask you to sign a release for a version of your story to be used on the NeuroPace website, Facebook, Instagram, Twitter and/or LinkedIn.

Neurostimulation devices to treat epilepsy — NeuroPace, Inc.

The first closed-loop device, the NeuroPace RNS System, was approved by the FDA for drug-resistant epilepsy in 2013 and demonstrated a median reduction in seizure frequency of 53% at two years and 72% at six years [6, 7]. Your username and password combination constitutes an electronic signature. Tailor the display of your patient's ECoG activity and events by selecting the time range and information you want to see

Epilepsy Patients receive help with new NeuroPace YouTube. For convenience, when NeuroPace establishes an account for you on PDMS we will also register you for the nSight Platform website and, Relevant ECoGs selected from PDMS to conveniently provide the detail you need to gain insight into electrographic events.

Neuropace NeuroPace, Inc. All questions or concerns regarding the NeuroPace® Patient Data Management System should be forwarded to: NeuroPace, Inc the NeuroPace Patient Data Management System (PDMS) using a Physician Programmer or Patient Remote Monitor